Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The PRECISION Study: A Phase II Study of 3 Fractions of Prostate SBRT With RayPilot System and HypoCath Image Guidance for Men With NCCN Low or Intermediate Risk Prostate Cancer

NCT06117059 is registered in ClinicalTrials.gov with NHS Lothian as lead sponsor.

NCT NCT06117059
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06117059 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The PRECISION Study: A Phase II Study of 3 Fractions of Prostate SBRT With RayPilot System and HypoCath Image Guidance for Men With NCCN Low or Intermediate Risk Prostate Cancer
Lead sponsor
NHS Lothian
Phase
Not applicable
Overall status
Recruiting
Start date
November 1, 2024
Completion date
November 1, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intermediate risk prostate cancer, localized prostate cancer, low risk prostate cancer